Display options
Share it on
Full text links
Silverchair Information Systems

J Pharm Pharmacol. 1981 Aug;33(8):500-6. doi: 10.1111/j.2042-7158.1981.tb13848.x.

The systemic bioavailability of buprenorphine by various routes of administration.

The Journal of pharmacy and pharmacology

D Brewster, M J Humphrey, M A Mcleavy

PMID: 6115924 DOI: 10.1111/j.2042-7158.1981.tb13848.x

Abstract

The systemic bioavailability of buprenorphine has been studied in female rats following single doses (200 microgram kg-1) administered by one of six different routes. Relative to the 100% bioavailability from the intraarterial route the mean bioavailabilities were intravenous, 98%; intrarectal, 54%; intrahepatoportal, 49%; sublingual, 13%; and intraduodenal, 9.7%. Area under the curve analysis of buprenorphine concentrations in blood showed the relative fractions of drug extracted (first pass) by gut, liver and lung to be 0.80, 0.50 and 0.02 respectively, In situ absorption studies showed that the poor availability of intraduodenally administered buprenorphine is not due to slow or incomplete absorption.

Cited by

Jurna I.
Schmerz. 1987 Jul;1(1):45-7. doi: 10.1007/BF02529121.
PMID: 18415576

Substances

MeSH terms

Publication Types

LinkOut - more resources